171 results
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
25 Apr 24
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
7:47am
workforce representation and increased community engagement by the company's employees;
◦Advancing climate action goals and increasing the company's
424B5
BMY
Bristol-Myers Squibb Co.
16 Feb 24
Prospectus supplement for primary offering
4:34pm
or indirectly.
According to the depositary, the foregoing information with respect to the depositary has been provided to the financial community
424B2
62rc rllc
13 Feb 24
Prospectus for primary offering
8:00am
DFAN14A
92vcnbon93pc45rz8i2n
22 Dec 23
Additional proxy materials by non-management
4:36pm
424B5
9s1wr5nds kjk78t8
1 Nov 23
Prospectus supplement for primary offering
4:16pm
424B3
i40kqp j3
30 Oct 23
Prospectus supplement
8:05am
DEFA14A
9fdno7un 14j42j9
10 Apr 23
Additional proxy soliciting materials
5:12pm
424B5
oq7shddiqkis5
17 Feb 22
Prospectus supplement for primary offering
4:47pm
424B3
qhtg6rzdvd0
15 Feb 22
Prospectus supplement
9:13am
8-K
EX-99.1
h1qbx4rjmkztmgx7b
16 Nov 21
Regulation FD Disclosure
9:20am